LET'S GET CONNECTED
REFLEXION AT ASTRO 2025
SEPTEMBER 28 - 30
WHEN THE TUMOR MOVES
THE DOSE DOES TOO.
We look forward to seeing you at the ASTRO Annual Meeting and sharing the latest clinical updates about SCINTIX biology-guided radiotherapy. Visit us at booth 1433 to learn more about the clinical progress on the current RefleXion platform and about our future next-generation RefleXion platform with SCINTIX therapy*.
VISIT OUR BOOTH
Visit us at booth 1433 to learn more about SCINTIX biology-guided radiotherapy clinical highlights and outcomes. You can attend a presentation, schedule a demo or get hands on with our interactive PET display.
FUTURE PLATFORM
Please stop by our booth for a first look at the future next-generation RefleXion platform with SCINTIX therapy. This future next-generation platform offers 20 times the sensitivity and is designed to broaden eligibility and to deliver SBRT-level precision. Schedule a private presentation by clicking below.
SCHEDULE A DEMO
Schedule a demo ahead of time or onsite. In this 20-minute session, you'll dive deep with our experts into the unique aspects of RefleXion treatment planning, including multi-target treatments, dose optimization, and hybrid SCINTIX therapy and SBRT treatments.
LEARN MORE ABOUT SCINTIX THERAPY
SCINTIX® technology is a novel therapy for patients with tumors in the lung or bone arising from primary and metastatic cancer. This breakthrough technology uses live, continuously updated data throughout the entire treatment session to determine where to deliver radiotherapy.
The future, next-generation, platform has not been approved by FDA, and its safety and effectiveness has not been established. It is not for sale